Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06471374 · ClinicalTrials.gov registry record · NA
Pathophysiology of Circadian Rhythm Delayed Sleep Wake Phase Disorder
A NA study of Delayed Sleep Phase Syndrome and Delayed Sleep Phase, sponsored by University of Colorado, Boulder.
- Recruiting
- Registry status
- NA
- Development phase
- 66
- Enrollment target
- 2
- Study locations
NCT06471374 is a NA study of Delayed Sleep Phase Syndrome and Delayed Sleep Phase that is actively recruiting participants, run by University of Colorado, Boulder. The registered enrollment target is 66 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT06471374, a NA study of Delayed Sleep Phase Syndrome and Delayed Sleep Phase, is actively recruiting participants, sponsored by University of Colorado, Boulder.
- RECRUITING
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this study is to understand factors that contribute to delayed sleep wake phase disorder (DSWPD). The investigators will examine whether patients with DSWPD exhibit alterations in circadian rhythms and sensitivity to light compared to healthy controls. The investigators will also test a new method of predicting circadian rhythms form a blood sample.
Conditions Studied
Interventions
- BEHAVIORAL Circadian rhythm assessment
- BEHAVIORAL Light sensitivity assessment
Study Locations (2)
Colorado
- University of Colorado - Boulder
Illinois
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2024-04-02 |
| Est. Completion | 2028-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06471374
The ClinicalTrials.gov registry entry for NCT06471374 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Boulder, which has 69 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Delayed Sleep Phase Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Circadian rhythm assessment is the first listed.
NCT06471374 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Colorado, Illinois.
Frequently Asked Questions
What is clinical trial NCT06471374 about?
NCT06471374 is a clinical study titled "Pathophysiology of Circadian Rhythm Delayed Sleep Wake Phase Disorder". The goal of this study is to understand factors that contribute to delayed sleep wake phase disorder (DSWPD). The investigators will examine whether patients with DSWPD exhibit alterations in circadian rhythms and sensitivity to light compared to healthy controls. The investigators will also test a ...
What is the current status of trial NCT06471374?
This trial is currently recruiting. It is a NA study. The enrollment target is 66 participants. The study started on 2024-04-02. Estimated completion is 2028-07.
What conditions does trial NCT06471374 study?
This clinical trial studies the following conditions: Delayed Sleep Phase Syndrome, Delayed Sleep Phase.
What interventions are being tested in trial NCT06471374?
The interventions under investigation include: Circadian rhythm assessment (BEHAVIORAL), Light sensitivity assessment (BEHAVIORAL).
Who is sponsoring clinical trial NCT06471374?
This trial is sponsored by University of Colorado, Boulder, which has 69 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06471374 being conducted?
This trial has 2 study locations across Colorado, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Delayed Sleep Phase Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.